Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janske Lock

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|October 30, 2014
[Haemophilia]Janneke I Loomans, Janske Lock, Marjolein Peters, et al.
Patient Education and Counseling|February 7, 2016
Achieving self-management of prophylactic treatment in adolescents: The case of haemophiliaLiesbeth Schrijvers, Marlène Beijlevelt-Van der Zande, Marjolein Peters, et al.
British Journal of Haematology|April 22, 2016
Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre studyLieSbeth H Schrijvers, Marlene Beijlevelt-van der Zande, Marjolein Peters, et al.
Haematologica|July 9, 2016
A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patientsHendrika Hazendonk, Karin Fijnvandraat, Janske Lock, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|October 30, 2014
[Haemophilia]Janneke I Loomans, Janske Lock, Marjolein Peters, et al.
Patient Education and Counseling|February 7, 2016
Achieving self-management of prophylactic treatment in adolescents: The case of haemophiliaLiesbeth Schrijvers, Marlène Beijlevelt-Van der Zande, Marjolein Peters, et al.
British Journal of Haematology|April 22, 2016
Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre studyLieSbeth H Schrijvers, Marlene Beijlevelt-van der Zande, Marjolein Peters, et al.
Haematologica|July 9, 2016
A population pharmacokinetic model for perioperative dosing of factor VIII in hemophilia A patientsHendrika Hazendonk, Karin Fijnvandraat, Janske Lock, et al.
Pageof 1